Year |
Citation |
Score |
2020 |
Tong J, Meyer JH, Boileau I, Ang LC, Fletcher PJ, Furukawa Y, Kish SJ. Serotonin transporter protein in autopsied brain of chronic users of cocaine. Psychopharmacology. PMID 32494974 DOI: 10.1007/S00213-020-05562-4 |
0.366 |
|
2020 |
Rathitharan G, Truong J, Tong J, McCluskey T, Meyer JH, Mizrahi R, Warsh J, Rusjan P, Kennedy JL, Houle S, Kish SJ, Boileau I. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA. Addiction Biology. e12876. PMID 32017280 DOI: 10.1111/Adb.12876 |
0.371 |
|
2020 |
Best LM, Williams B, Le Foll B, Mansouri E, Bazinet RP, Lin L, De Luca V, Lagzdins D, Rusjan P, Tyndale RF, Wilson AA, Hendershot CS, Heilig M, Houle S, Tong J, ... Kish SJ, et al. Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31910433 DOI: 10.1038/S41386-020-0606-2 |
0.356 |
|
2020 |
Truong J, Best LM, McCluskey T, Tong J, Rusjan PM, Meyer JH, Le Foll B, Hendershot CS, Rubin-Kahana DS, Warsh J, Houle S, Kish SJ, Boileau I. Investigating Brain Monoamine Oxidase B Status in Alcohol Use Disorder With the Positron Emission Tomography (PET) Tracer [C-11]SL25.1188 Biological Psychiatry. 87: S407. DOI: 10.1016/J.Biopsych.2020.02.1203 |
0.304 |
|
2019 |
Mansouri E, Nobrega JN, Hill MN, Tyndale RF, Lee FS, Hendershot CS, Best LM, Di Ciano P, Balsevich G, Sloan ME, Kish SJ, Tong J, Le Foll B, Boileau I. D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31775159 DOI: 10.1038/S41386-019-0580-8 |
0.36 |
|
2019 |
Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ. Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19858003. PMID 31220997 DOI: 10.1177/0271678X19858003 |
0.369 |
|
2019 |
Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, Rajkowska G, Wang J, Bagby M, Mizrahi R, Varughese B, Houle S, Meyer JH. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study. Jama Psychiatry. PMID 30840042 DOI: 10.1001/Jamapsychiatry.2019.0044 |
0.313 |
|
2019 |
Mansouri E, Tyndale RF, Hendershot CS, Best LM, Di Ciano P, Hill M, Nobrega JJ, Sloan M, Kish S, Tong J, Le Foll B, Boileau I. S203. Fatty Acid Amide Hydrolase Polymorphism C385A Associated With Dopamine D2/3 Receptor Levels: A PET Study With [11C]-(+)-PHNO Biological Psychiatry. 85: S376. DOI: 10.1016/J.Biopsych.2019.03.954 |
0.311 |
|
2018 |
Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug and Alcohol Dependence. 190: 20-28. PMID 29960919 DOI: 10.1016/J.Drugalcdep.2018.05.021 |
0.679 |
|
2018 |
Matthews BA, Tong J, Attwells S, Xu X, Le A, Kish SJ, Meyer JH. Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure. Drug and Alcohol Dependence. 185: 398-405. PMID 29549852 DOI: 10.1016/J.Drugalcdep.2017.11.036 |
0.319 |
|
2017 |
Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain : a Journal of Neurology. 140: 2460-2474. PMID 29050386 DOI: 10.1093/Brain/Awx172 |
0.466 |
|
2017 |
Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder. Jama Psychiatry. PMID 28636705 DOI: 10.1001/Jamapsychiatry.2017.1567 |
0.338 |
|
2017 |
Raitsin S, Tong J, Kish S, Xu X, Magomedova L, Cummins C, Andreazza AC, Scola G, Baker G, Meyer JH. Subchronic Glucocorticoids, Glutathione Depletion and a Postpartum Model Elevate Monoamine Oxidase A Activity in the Prefrontal Cortex of Rats. Brain Research. PMID 28435083 DOI: 10.1016/J.Brainres.2017.03.032 |
0.347 |
|
2017 |
Furukawa Y, Hornykiewicz O, Kish S. Characteristic neurochemical changes in the substantia nigra (SN) and striatum of symptomatic versus asymptomatic dopa-responsive dystonia (DRD) Journal of the Neurological Sciences. 381: 178. DOI: 10.1016/J.Jns.2017.08.515 |
0.322 |
|
2016 |
Payer D, Williams B, Mansouri E, Stevanovski S, Nakajima S, Le Foll B, Kish S, Houle S, Mizrahi R, George SR, George TP, Boileau I. Corticotropin-releasing hormone and dopamine release in healthy individuals. Psychoneuroendocrinology. 76: 192-196. PMID 27951520 DOI: 10.1016/J.Psyneuen.2016.11.034 |
0.34 |
|
2016 |
Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: Possible functional implications. The European Journal of Neuroscience. PMID 27741357 DOI: 10.1111/Ejn.13435 |
0.435 |
|
2016 |
Tong J, Mizrahi R, Houle S, Kish SJ, Boileau I, Nobrega J, Rusjan PM, Wilson AA. Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27650910 DOI: 10.1177/0271678X16668890 |
0.347 |
|
2016 |
Kish SJ, Boileau I, Callaghan RC, Tong J. Brain dopamine neurone "damage": methamphetamine users vs. parkinson's disease ─ A critical assessment of the evidence. The European Journal of Neuroscience. PMID 27519465 DOI: 10.1111/Ejn.13363 |
0.437 |
|
2016 |
Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ. A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia. Neurology. PMID 27488599 DOI: 10.1212/Wnl.0000000000003065 |
0.41 |
|
2016 |
Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27353309 DOI: 10.1038/Npp.2016.108 |
0.375 |
|
2016 |
Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [(11)C]CURB. Biological Psychiatry. PMID 27345297 DOI: 10.1016/J.Biopsych.2016.04.012 |
0.369 |
|
2016 |
Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Do glutathione levels decline in aging human brain? Free Radical Biology & Medicine. PMID 26845616 DOI: 10.1016/J.Freeradbiomed.2016.01.029 |
0.696 |
|
2015 |
Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Neurology. PMID 26718579 DOI: 10.1212/Wnl.0000000000002285 |
0.331 |
|
2015 |
Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ. Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26321315 DOI: 10.1038/Npp.2015.267 |
0.396 |
|
2015 |
Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Neurobiology of Disease. 82: 243-253. PMID 26102022 DOI: 10.1016/J.Nbd.2015.06.010 |
0.365 |
|
2015 |
Boileau I, Rusjan PM, Williams B, Mansouri E, Mizrahi R, De Luca V, Johnson DS, Wilson AA, Houle S, Kish SJ, Tong J. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26082009 DOI: 10.1038/Jcbfm.2015.133 |
0.344 |
|
2015 |
Boileau I, Tyndale RF, Williams B, Mansouri E, Westwood DJ, Foll BL, Rusjan PM, Mizrahi R, De Luca V, Zhou Q, Wilson AA, Houle S, Kish SJ, Tong J. The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26036940 DOI: 10.1038/Jcbfm.2015.119 |
0.305 |
|
2015 |
Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 160-6. PMID 25641350 DOI: 10.1002/Mds.26135 |
0.386 |
|
2015 |
Furukawa Y, Kish SJ. Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia Brain. 138: e351. PMID 25416181 DOI: 10.1093/Brain/Awu325 |
0.32 |
|
2015 |
Payer D, Park MT, Kish S, Lerch J, Boileau I, Chakravarty MM. Exploring brain morphology in poly-stimulant abuse: shape, volume, and surface area abnormalities in Ecstasy-cocaine- and methamphetamine-preferring individuals Drug and Alcohol Dependence. 146: e65. DOI: 10.1016/J.Drugalcdep.2014.09.546 |
0.321 |
|
2014 |
Tong J, Fitzmaurice P, Furukawa Y, Schmunk GA, Wickham DJ, Ang LC, Sherwin A, McCluskey T, Boileau I, Kish SJ. Is brain gliosis a characteristic of chronic methamphetamine use in the human? Neurobiology of Disease. 67: 107-18. PMID 24704312 DOI: 10.1016/J.Nbd.2014.03.015 |
0.408 |
|
2014 |
Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry. 19: 1305-13. PMID 24322203 DOI: 10.1038/Mp.2013.163 |
0.355 |
|
2013 |
Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 863-71. PMID 23403377 DOI: 10.1038/Jcbfm.2013.19 |
0.34 |
|
2013 |
Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 108: 953-63. PMID 23167711 DOI: 10.1111/Add.12066 |
0.333 |
|
2012 |
Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1618-24. PMID 23038412 DOI: 10.1002/Mds.25109 |
0.32 |
|
2012 |
Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1353-9. PMID 22279219 DOI: 10.1523/Jneurosci.4371-11.2012 |
0.365 |
|
2012 |
Sacher J, Rabiner EA, Clark M, Rusjan P, Soliman A, Boskovic R, Kish SJ, Wilson AA, Houle S, Meyer JH. Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 443-6. PMID 22186668 DOI: 10.1038/Jcbfm.2011.184 |
0.342 |
|
2012 |
Mann A, Miksys SL, Gaedigk A, Kish SJ, Mash DC, Tyndale RF. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiology of Aging. 33: 2160-71. PMID 21958961 DOI: 10.1016/J.Neurobiolaging.2011.08.014 |
0.346 |
|
2012 |
Callaghan RC, Cunningham JK, Sykes J, Kish SJ. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug and Alcohol Dependence. 120: 35-40. PMID 21794992 DOI: 10.1016/J.Drugalcdep.2011.06.013 |
0.358 |
|
2011 |
Tong J, Boileau I, Furukawa Y, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 2065-75. PMID 21522164 DOI: 10.1038/Jcbfm.2011.63 |
0.414 |
|
2011 |
Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ. Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiology of Disease. 41: 458-68. PMID 21029775 DOI: 10.1016/J.Nbd.2010.10.017 |
0.373 |
|
2010 |
Callaghan RC, Cunningham JK, Sajeev G, Kish SJ. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2333-9. PMID 20737543 DOI: 10.1002/Mds.23263 |
0.33 |
|
2010 |
Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, et al. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain : a Journal of Neurology. 133: 1779-97. PMID 20483717 DOI: 10.1093/Brain/Awq103 |
0.399 |
|
2010 |
Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse (New York, N.Y.). 64: 417-20. PMID 20169578 DOI: 10.1002/Syn.20743 |
0.311 |
|
2010 |
Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain : a Journal of Neurology. 133: 172-88. PMID 19903734 DOI: 10.1093/Brain/Awp282 |
0.326 |
|
2010 |
Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. Journal of Psychopharmacology (Oxford, England). 24: 281-4. PMID 18832433 DOI: 10.1177/0269881108097724 |
0.407 |
|
2010 |
Boileau I, Guttman M, Adams JR, Houle S, Tong J, Rusjan P, Wilson A, Kapur S, Kish SJ. Parkinson's disease, impulse control disorder and the D3 dopamine receptor system: Preliminary PET imaging studies with [11C](+)PHNO comparison with [11C]racloride Neuroimage. 52: S84. DOI: 10.1016/J.Neuroimage.2010.04.067 |
0.332 |
|
2009 |
Roedding AS, Gao AF, Wu AM, Li PP, Kish SJ, Warsh JJ. TRPC3 protein is expressed across the lifespan in human prefrontal cortex and cerebellum. Brain Research. 1260: 1-6. PMID 19168035 DOI: 10.1016/J.Brainres.2008.12.069 |
0.345 |
|
2009 |
Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/Brain/Awn337 |
0.354 |
|
2009 |
Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Brain serotonin transporter in human methamphetamine users. Psychopharmacology. 202: 649-61. PMID 18841348 DOI: 10.1007/S00213-008-1346-X |
0.395 |
|
2009 |
Kish S, McCluskey T, Meyer J, Warsh J, Wilkins D, Wilson A, Houle S. Serotonin Transporter Concentration is Decreased in Cerebral Cortex but not in Striatum of Chronic MDMA (ecstasy) Users European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70667-4 |
0.422 |
|
2008 |
Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9850-6. PMID 18815269 DOI: 10.1523/Jneurosci.3008-08.2008 |
0.388 |
|
2008 |
Tong J, Wilson AA, Boileau I, Houle S, Kish SJ. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse (New York, N.Y.). 62: 873-6. PMID 18720517 DOI: 10.1002/Syn.20573 |
0.356 |
|
2008 |
Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1776-80. PMID 18661545 DOI: 10.1002/Mds.22212 |
0.305 |
|
2008 |
Kish SJ. Pharmacologic mechanisms of crystal meth. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 178: 1679-82. PMID 18559805 DOI: 10.1503/Cmaj.071675 |
0.419 |
|
2008 |
Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ. Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology. 55: 41-6. PMID 18538358 DOI: 10.1016/J.Neuropharm.2008.04.019 |
0.41 |
|
2008 |
Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain : a Journal of Neurology. 131: 120-31. PMID 17956909 DOI: 10.1093/Brain/Awm239 |
0.425 |
|
2007 |
Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ. Brain levels of neuropeptides in human chronic methamphetamine users. Neuropharmacology. 53: 447-54. PMID 17688891 DOI: 10.1016/J.Neuropharm.2007.06.009 |
0.461 |
|
2007 |
Tong J, Hornykiewicz O, Furukawa Y, Kish SJ. Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. Journal of Neurochemistry. 102: 1691-702. PMID 17484728 DOI: 10.1111/J.1471-4159.2007.04636.X |
0.404 |
|
2007 |
Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 523-8. PMID 17437611 DOI: 10.1111/J.1468-1331.2007.01727.X |
0.393 |
|
2006 |
Tong J, Hornykiewicz O, Kish SJ. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Archives of Neurology. 63: 1724-8. PMID 17172611 DOI: 10.1001/Archneur.63.12.1724 |
0.412 |
|
2006 |
Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 319: 703-9. PMID 16857724 DOI: 10.1124/Jpet.106.109173 |
0.464 |
|
2006 |
Ross BM, Hughes B, Kish SJ, Warsh JJ. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disorders. 8: 265-70. PMID 16696828 DOI: 10.1111/J.1399-5618.2006.00299.X |
0.316 |
|
2006 |
Tong J, Hornykiewicz O, Kish SJ. Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. Journal of Neurochemistry. 96: 349-54. PMID 16336226 DOI: 10.1111/J.1471-4159.2005.03546.X |
0.412 |
|
2005 |
Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nuclear Medicine and Biology. 32: 123-8. PMID 15721757 DOI: 10.1016/J.Nucmedbio.2004.10.001 |
0.395 |
|
2005 |
Furukawa Y, Guttman M, Nakamura S, Kish SJ. Dopa-Responsive Dystonia Rinshō Shinkeigaku Clinical Neurology. 46: 209-229. DOI: 10.1007/978-1-60761-835-5_24 |
0.313 |
|
2004 |
Mirecki A, Fitzmaurice P, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Sherwin A, Nobrega JN, Forman HJ, Kish SJ. Brain antioxidant systems in human methamphetamine users. Journal of Neurochemistry. 89: 1396-408. PMID 15189342 DOI: 10.1111/J.1471-4159.2004.02434.X |
0.432 |
|
2004 |
Siegal D, Erickson J, Varoqui H, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse (New York, N.Y.). 52: 223-32. PMID 15103689 DOI: 10.1002/Syn.20020 |
0.426 |
|
2004 |
Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Annals of Neurology. 55: 125-9. PMID 14705122 DOI: 10.1002/Ana.10814 |
0.411 |
|
2004 |
Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Why is parkinsonism not a feature of human methamphetamine users? Brain : a Journal of Neurology. 127: 363-70. PMID 14645148 DOI: 10.1093/Brain/Awh046 |
0.71 |
|
2003 |
Kish SJ. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1219-23. PMID 14639660 DOI: 10.1002/Mds.10643 |
0.347 |
|
2003 |
Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry. 87: 574-85. PMID 14535941 DOI: 10.1046/J.1471-4159.2003.02017.X |
0.374 |
|
2003 |
Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 969-76. PMID 14502663 DOI: 10.1002/Mds.10486 |
0.349 |
|
2003 |
Andreopoulos S, Li PP, Siu KP, Kish SJ, Warsh JJ. Altered CTX-catalyzed and endogenous [32P]ADP-ribosylation of stimulatory G protein alphas isoforms in postmortem bipolar affective disorder temporal cortex. Journal of Neuroscience Research. 72: 638-45. PMID 12749029 DOI: 10.1002/Jnr.10620 |
0.302 |
|
2003 |
Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ. Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. The American Journal of Psychiatry. 160: 896-903. PMID 12727693 DOI: 10.1176/Appi.Ajp.160.5.896 |
0.393 |
|
2002 |
Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. International Review of Neurobiology. 53: 341-85. PMID 12512346 DOI: 10.1016/S0074-7742(02)53013-0 |
0.304 |
|
2002 |
Furukawa Y, Kapatos G, Haycock JW, Worsley J, Wong H, Kish SJ, Nygaard TG. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Annals of Neurology. 51: 637-41. PMID 12112113 DOI: 10.1002/Ana.10175 |
0.413 |
|
2002 |
Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Brain proteasomal function in sporadic Parkinson's disease and related disorders. Annals of Neurology. 51: 779-82. PMID 12112087 DOI: 10.1002/Ana.10207 |
0.411 |
|
2002 |
Fitzmaurice PS, Bamsey CL, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Brain aconitase activity is not decreased in progressive supranuclear palsy Neurology. 59: 137-138. PMID 12105325 DOI: 10.1212/Wnl.59.1.137 |
0.421 |
|
2002 |
Ross BM, Moszczynska A, Peretti FJ, Adams V, Schmunk GA, Kalasinsky KS, Ang L, Mamalias N, Turenne SD, Kish SJ. Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence. 67: 73-9. PMID 12062780 DOI: 10.1016/S0376-8716(02)00022-4 |
0.7 |
|
2002 |
Kish SJ. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacology, Biochemistry, and Behavior. 71: 845-55. PMID 11888575 DOI: 10.1016/S0091-3057(01)00708-0 |
0.394 |
|
2001 |
Tong J, Ross BM, Sherwin AL, Kish SJ. Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain. Neurochemistry International. 39: 117-25. PMID 11408090 DOI: 10.1016/S0197-0186(01)00016-X |
0.433 |
|
2001 |
Kish SJ, Kalasinsky KS, Schmunk G, Furukawa Y, Guttman M, Ang L. Dopaminergic changes in human brain following acute exposure to γ-hydroxybutyrate Neurology. 56: 1602-1603. PMID 11402130 DOI: 10.1212/Wnl.56.11.1602 |
0.401 |
|
2001 |
Guttman M, Stewart D, Hussey D, Wilson A, Houle S, Kish S. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology. 56: 1559-64. PMID 11402115 DOI: 10.1212/Wnl.56.11.1559 |
0.342 |
|
2001 |
Kalasinsky KS, Dixon MM, Schmunk GA, Kish SJ. Blood, brain, and hair GHB concentrations following fatal ingestion Journal of Forensic Sciences. 46: 728-730. PMID 11373018 DOI: 10.1520/Jfs15032J |
0.324 |
|
2001 |
Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW. Striatal dopaminergic and serotonergic markers in human heroin users Neuropsychopharmacology. 24: 561-567. PMID 11282256 DOI: 10.1016/S0893-133X(00)00209-8 |
0.425 |
|
2001 |
Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, Furukawa Y, Guttman M, Kish SJ. Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users Forensic Science International. 116: 163-169. PMID 11182268 DOI: 10.1016/S0379-0738(00)00368-6 |
0.427 |
|
2001 |
Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience. 102: 899-904. PMID 11182251 DOI: 10.1016/S0306-4522(00)00501-7 |
0.711 |
|
2000 |
Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ. Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molecular Psychiatry. 5: 664-72. PMID 11126397 DOI: 10.1038/Sj.Mp.4000760 |
0.701 |
|
2000 |
Kalasinsky KS, Bosy TZ, Schmunk GA, Ang L, Adams VI, Gore SB, Smialek J, Furukawa Y, Guttman M, Kish SJ. Regional distribution of cocaine in postmortem brain of chronic human cocaine users Journal of Forensic Sciences. 45: 1041-1048. PMID 11005179 DOI: 10.1520/Jfs14828J |
0.375 |
|
2000 |
Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user Neurology. 55: 294-296. PMID 10908909 DOI: 10.1212/Wnl.55.2.294 |
0.439 |
|
2000 |
McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J, Schmunk G, Adams V, Kish SJ. The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. Journal of Neurochemistry. 74: 2120-6. PMID 10800957 DOI: 10.1046/J.1471-4159.2000.0742120.X |
0.366 |
|
2000 |
Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J, Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 294-300. PMID 10752579 DOI: 10.1002/1531-8257(200003)15:2<294::Aid-Mds1013>3.0.Co;2-D |
0.724 |
|
2000 |
Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299 DOI: 10.1212/Wnl.54.5.1193 |
0.372 |
|
1999 |
Fields A, Li PP, Kish SJ, Warsh JJ. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder Journal of Neurochemistry. 73: 1704-1710. PMID 10501218 DOI: 10.1046/J.1471-4159.1999.731704.X |
0.396 |
|
1999 |
Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 53: 1032-41. PMID 10496263 DOI: 10.1212/Wnl.53.5.1032 |
0.437 |
|
1999 |
Furukawa Y, Kish SJ. Dopa-responsive dystonia: Recent advances and remaining issues to be addressed Movement Disorders. 14: 709-715. PMID 10495030 DOI: 10.1002/1531-8257(199909)14:5<709::Aid-Mds1001>3.0.Co;2-T |
0.349 |
|
1999 |
Fallbrook A, Turenne SD, Mamalias N, Kish SJ, Ross BM. Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Research. 834: 207-10. PMID 10407117 DOI: 10.1016/S0006-8993(99)01570-X |
0.425 |
|
1999 |
Kish SJ, Kalasinsky KS, Furukawa Y, Guttman M, Lang A, Li L, Adams V, Reiber G, Anthony RA, Anderson W, Smialek J, DiStefano L. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin Molecular Psychiatry. 4: 26-32. PMID 10089005 DOI: 10.1038/Sj.Mp.4000462 |
0.436 |
|
1999 |
Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821: 407-13. PMID 10064828 DOI: 10.1016/S0006-8993(99)01123-3 |
0.693 |
|
1999 |
Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozić S, Pandolfo M, Lamarche J, DiStefano L, Chang LJ. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? Journal of Neurochemistry. 72: 700-7. PMID 9930743 DOI: 10.1046/J.1471-4159.1999.0720700.X |
0.412 |
|
1998 |
Moszczynska A, Turenne S, Kish SJ. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters. 255: 49-52. PMID 9839724 DOI: 10.1016/S0304-3940(98)00711-3 |
0.684 |
|
1998 |
Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross BM, Nance M, Schut L, Ang L, DiStefano L. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Archives of Neurology. 55: 1299-304. PMID 9779656 DOI: 10.1001/Archneur.55.10.1299 |
0.366 |
|
1998 |
Eder K, Kish SJ, Kirchgessner M, Ross BM. Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 813-9. PMID 9756151 DOI: 10.1002/Mds.870130510 |
0.388 |
|
1998 |
Furukawa Y, Kish SJ. Influence of development and aging on brain biopterin: Implications for dopa-responsive dystonia onset Neurology. 51: 632-634. PMID 9710058 DOI: 10.1212/Wnl.51.2.632 |
0.331 |
|
1998 |
Morrison LD, Cao XC, Kish SJ. Ornithine decarboxylase in human brain: Influence of aging, regional distribution, and Alzheimer's disease Journal of Neurochemistry. 71: 288-294. PMID 9648877 DOI: 10.1046/J.1471-4159.1998.71010288.X |
0.455 |
|
1998 |
Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM, Snow BJ, Calne DB. Hereditary form of parkinsonism--dementia. Annals of Neurology. 43: 768-81. PMID 9629847 DOI: 10.1002/Ana.410430612 |
0.381 |
|
1998 |
Ross BM, Moszczynska A, Erlich J, Kish SJ. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. Neuroscience. 83: 791-8. PMID 9483562 DOI: 10.1016/S0306-4522(97)00454-5 |
0.708 |
|
1998 |
Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. Journal of Neurochemistry. 70: 786-93. PMID 9453575 DOI: 10.1046/J.1471-4159.1998.70020786.X |
0.705 |
|
1997 |
Bettendorff L, Mastrogiacomo F, Wins P, Kish SJ, Grisar T, Ball MJ. Low thiamine diphosphate levels in brains of patients with frontal lobe degeneration of the non-Alzheimer's type. Journal of Neurochemistry. 69: 2005-10. PMID 9349545 DOI: 10.1046/J.1471-4159.1997.69052005.X |
0.382 |
|
1997 |
Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, Houle S. [11C]RTI-32 PET studies of the dopamine transporter in early dopa- naive Parkinson's disease: Implications for the symptomatic threshold Neurology. 48: 1578-1583. PMID 9191769 DOI: 10.1212/Wnl.48.6.1578 |
0.356 |
|
1997 |
Ross BM, Hudson C, Erlich J, Warsh JJ, Kish SJ. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Archives of General Psychiatry. 54: 487-94. PMID 9152103 DOI: 10.1001/Archpsyc.1997.01830170113015 |
0.325 |
|
1997 |
Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids. 32: 351-8. PMID 9113621 DOI: 10.1007/S11745-997-0044-X |
0.687 |
|
1997 |
Kish SJ, Guttman M, Robitaille Y, el-Awar M, Chang LJ, Levey AI. Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1. Neurology. 48: 1109-11. PMID 9109912 DOI: 10.1212/Wnl.48.4.1109 |
0.342 |
|
1997 |
Mathews R, Li PP, Young LT, Kish SJ, Warsh JJ. Increased Gα(q/11) immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder Biological Psychiatry. 41: 649-656. PMID 9066988 DOI: 10.1016/S0006-3223(96)00113-8 |
0.306 |
|
1997 |
Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ. Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. Journal of Neurochemistry. 68: 297-304. PMID 8978738 DOI: 10.1046/J.1471-4159.1997.68010297.X |
0.401 |
|
1996 |
Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G, Hays AP. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Annals of Neurology. 39: 158-65. PMID 8967746 DOI: 10.1002/Ana.410390204 |
0.386 |
|
1996 |
Ross BM, Moszczynska A, Kalasinsky K, Kish SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. Journal of Neurochemistry. 67: 2620-3. PMID 8931499 DOI: 10.1046/J.1471-4159.1996.67062620.X |
0.712 |
|
1996 |
Young LT, Asghari V, Li PP, Kish SJ, Fahnestock M, Warsh JJ. Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. Brain Research. Molecular Brain Research. 42: 45-50. PMID 8915579 DOI: 10.1016/S0169-328X(96)00112-X |
0.325 |
|
1996 |
Bettendorff L, Mastrogiacomo F, LaMarche J, Dožić S, Kish SJ. Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1 Movement Disorders. 11: 437-439. PMID 8813226 DOI: 10.1002/Mds.870110415 |
0.436 |
|
1996 |
Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, Niznik HB, Hornykiewicz O, Pifl C, Kish SJ. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology. 47: 718-26. PMID 8797470 DOI: 10.1212/Wnl.47.3.718 |
0.348 |
|
1996 |
Lopes-Cendes I, Maciel P, Kish S, Gaspar C, Robitaille Y, Clark HB, Koeppen AH, Nance M, Schut L, Silveira I, Coutinho P, Sequeiros J, Rouleau GA. Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Annals of Neurology. 40: 199-206. PMID 8773601 DOI: 10.1002/Ana.410400211 |
0.346 |
|
1996 |
Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. Journal of Neurochemistry. 67: 1328-31. PMID 8752143 DOI: 10.1046/J.1471-4159.1996.67031328.X |
0.373 |
|
1996 |
Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine. 2: 699-703. PMID 8640565 DOI: 10.1038/Nm0696-699 |
0.37 |
|
1996 |
Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA, Warsh JJ. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain Journal of Neurochemistry. 66: 2402-2409. PMID 8632163 DOI: 10.1046/J.1471-4159.1996.66062402.X |
0.367 |
|
1996 |
Wilson JM, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat Journal of Neuroscience. 16: 3507-3510. PMID 8627383 DOI: 10.1523/Jneurosci.16-10-03507.1996 |
0.398 |
|
1996 |
Mastrogiacomo F, Lindsay JG, Bettendorff L, Rice J, Kish SJ. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Annals of Neurology. 39: 592-598. PMID 8619544 DOI: 10.1002/Ana.410390508 |
0.382 |
|
1996 |
Mastrogiacomo F, Bettendorff L, Grisar T, Kish SJ. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease Annals of Neurology. 39: 585-591. PMID 8619543 DOI: 10.1002/Ana.410390507 |
0.381 |
|
1996 |
Bettendorff L, Mastrogiacomo F, Kish SJ, Grisar T. Thiamine, thiamine phosphates, and their metabolizing enzymes in human brain Journal of Neurochemistry. 66: 250-258. PMID 8522961 DOI: 10.1046/J.1471-4159.1996.66010250.X |
0.405 |
|
1995 |
Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathologica. 90: 572-81. PMID 8615077 DOI: 10.1007/Bf00318569 |
0.332 |
|
1995 |
Ross BM, Sherwin AL, Kish SJ. Multiple forms of the enzyme glycerophosphodiesterase are present in human brain. Lipids. 30: 1075-81. PMID 8614297 DOI: 10.1007/Bf02536607 |
0.391 |
|
1995 |
Morrison LD, Kish SJ. Brain polyamine levels are altered in Alzheimer's disease Neuroscience Letters. 197: 5-8. PMID 8545054 DOI: 10.1016/0304-3940(95)11881-V |
0.422 |
|
1995 |
Zhong XH, Haycock JW, Shannak K, Robitaille Y, Fratkin J, Koeppen AH, Hornykiewicz O, Kish SJ. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 10-7. PMID 7885342 DOI: 10.1002/Mds.870100104 |
0.375 |
|
1995 |
Ross BM, Kim DK, Bonventre JV, Kish SJ. Characterization of a novel phospholipase A2 activity in human brain. Journal of Neurochemistry. 64: 2213-21. PMID 7722506 DOI: 10.1046/J.1471-4159.1995.64052213.X |
0.391 |
|
1995 |
Morrison LD, Becker L, Ang LC, Kish SJ. Polyamines in human brain: regional distribution and influence of aging. Journal of Neurochemistry. 65: 636-42. PMID 7616219 DOI: 10.1046/J.1471-4159.1995.65020636.X |
0.416 |
|
1994 |
Morrison LD, Sherwin AL, Carmant L, Kish SJ. Activity of S-adenosylmethionine decarboxylase, a key regulatory enzyme in polyamine biosynthesis, is increased in epileptogenic human cortex. Archives of Neurology. 51: 581-4. PMID 8198469 DOI: 10.1001/Archneur.1994.00540180059014 |
0.332 |
|
1994 |
Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, Pristupa ZB, Dixon LM, Kish SJ. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2966-79. PMID 8182452 DOI: 10.1523/Jneurosci.14-05-02966.1994 |
0.356 |
|
1994 |
Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Research. 639: 33-41. PMID 8180836 DOI: 10.1016/0006-8993(94)91761-2 |
0.428 |
|
1994 |
Joffe RT, Nobrega JN, Kish SJ, Calvo R, Dixon LM, Wilson JM, Morreale de Escobar G. Regional thyroid hormone levels in rat brain Psychoneuroendocrinology. 19: 773-777. PMID 7991764 DOI: 10.1016/0306-4530(94)90024-8 |
0.341 |
|
1994 |
Ross BM, Kish SJ. Characterization of lysophospholipid metabolizing enzymes in human brain. Journal of Neurochemistry. 63: 1839-48. PMID 7931340 DOI: 10.1046/J.1471-4159.1994.63051839.X |
0.391 |
|
1994 |
Kish SJ, Chang LJ, Dixon LM, Robitaille Y, DiStefano L. Cerebellar glutamate metabolizing enzymes in spinocerebellar ataxia type I. Metabolic Brain Disease. 9: 97-103. PMID 7914669 DOI: 10.1007/Bf01996077 |
0.355 |
|
1994 |
Young LT, Li PP, Kish SJ, Warsh JJ. Cerebral cortex β-adrenoceptor binding in bipolar affective disorder Journal of Affective Disorders. 30: 89-92. PMID 7911133 DOI: 10.1016/0165-0327(94)90035-3 |
0.303 |
|
1994 |
Mastrogiacomo F, Kish SJ. Cerebellar α-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1 Annals of Neurology. 35: 624-626. PMID 7910005 DOI: 10.1002/Ana.410350519 |
0.365 |
|
1994 |
Rajput AH, Gibb WR, Zhong XH, Shannak KS, Kish S, Chang LG, Hornykiewicz O. Dopa-responsive dystonia: pathological and biochemical observations in a case. Annals of Neurology. 35: 396-402. PMID 7908789 DOI: 10.1002/Ana.410350405 |
0.39 |
|
1994 |
Wilson JM, Carroll ME, Lac ST, DiStefano LM, Kish SJ. Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine Neuroscience Letters. 180: 29-32. PMID 7877755 DOI: 10.1016/0304-3940(94)90906-7 |
0.321 |
|
1994 |
Wilson JM, Nobrega J, Corrigall WA, Coen KM, Shannak K, Kish SJ. Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine Brain Research. 668: 39-45. PMID 7704616 DOI: 10.1016/0006-8993(94)90508-8 |
0.36 |
|
1994 |
Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder Biological Psychiatry. 35: 121-127. PMID 7513191 DOI: 10.1016/0006-3223(94)91201-7 |
0.377 |
|
1993 |
Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. Journal of Neurochemistry. 61: 890-8. PMID 8395565 DOI: 10.1111/J.1471-4159.1993.Tb03600.X |
0.341 |
|
1993 |
Trevor Young L, Li PP, Siu KP, Kish SJ, Warsh JJ. Regional distribution of guanine nucleotide binding proteins (Gs and Gi α) in human brain: correlation with adenylyl cyclase activity Neurochemistry International. 22: 285-291. PMID 8382985 DOI: 10.1016/0197-0186(93)90057-C |
0.377 |
|
1993 |
Morrison LD, Bergeron C, Kish SJ. Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease Neuroscience Letters. 154: 141-144. PMID 8361629 DOI: 10.1016/0304-3940(93)90191-M |
0.442 |
|
1993 |
Morrison LD, Becker L, Kish SJ. S-adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging Developmental Brain Research. 73: 237-241. PMID 8353934 DOI: 10.1016/0165-3806(93)90143-X |
0.441 |
|
1993 |
Nitsch RM, Blusztajn JK, Doyle FM, Robitaille Y, Wurtman RJ, Growdon JH, Kish SJ. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 161: 191-4. PMID 8272265 DOI: 10.1016/0304-3940(93)90291-R |
0.395 |
|
1993 |
Mastrogiacomo F, Bergeron C, Kish SJ. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Journal of Neurochemistry. 61: 2007-2014. PMID 8245957 DOI: 10.1111/J.1471-4159.1993.Tb07436.X |
0.398 |
|
1992 |
Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 642-8. PMID 1729408 DOI: 10.1111/J.1471-4159.1992.Tb09766.X |
0.39 |
|
1992 |
Wilson JM, Nobrega JN, Corrigall W, Shannak K, Deck JHN, Kish SJ. Influence of chronic cocaine on monoamine neurotransmitters in human brain and animal model: Preliminary observations Annals of the New York Academy of Sciences. 654: 461-463. PMID 1632604 DOI: 10.1111/J.1749-6632.1992.Tb25999.X |
0.363 |
|
1992 |
Kish SJ, Mamelak M, Slimovitch C, Dixon LM, Lewis A, Shannak K, DiStefano L, Chang LJ, Hornykiewicz O. Brain neurotransmitter changes in human narcolepsy. Neurology. 42: 229-34. PMID 1370862 DOI: 10.1212/Wnl.42.1.229 |
0.447 |
|
1992 |
Kish SJ, Robitaille Y, el-Awar M, Clark B, Schut L, Ball MJ, Young LT, Currier R, Shannak K. Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology. 42: 1573-7. PMID 1353622 DOI: 10.1212/Wnl.42.8.1573 |
0.396 |
|
1992 |
Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN. Brain cytochrome oxidase in Alzheimer's disease. Journal of Neurochemistry. 59: 776-9. PMID 1321237 DOI: 10.1111/J.1471-4159.1992.Tb09439.X |
0.431 |
|
1992 |
Petrasek JS, Nobrega JN, Kish SJ, Burnham WM. Autoradiographic analysis of [35S]TBPS binding in entorhinal cortex-kindled rat brains. Brain Research. 570: 167-72. PMID 1319792 DOI: 10.1016/0006-8993(92)90578-W |
0.344 |
|
1992 |
Kish SJ, Robitaille Y, Schut L, el-Awar M, Ball MJ, Shannak K. Normal serotonin but elevated 5-hydroxyindoleacetic acid concentration in cerebellar cortex of patients with dominantly-inherited olivopontocerebellar atrophy. Neuroscience Letters. 144: 84-6. PMID 1279488 DOI: 10.1016/0304-3940(92)90721-I |
0.359 |
|
1991 |
Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ. Postmortem cerebral cortex Gs α-subunit levels are elevated in bipolar affective disorder Brain Research. 553: 323-326. PMID 1933291 DOI: 10.1016/0006-8993(91)90843-K |
0.331 |
|
1991 |
el-Awar M, Kish S, Oscar-Berman M, Robitaille Y, Schut L, Freedman M. Selective delayed alternation deficits in dominantly inherited olivopontocerebellar atrophy. Brain and Cognition. 16: 121-9. PMID 1930971 DOI: 10.1016/0278-2626(91)90001-O |
0.34 |
|
1991 |
Warsh JJ, Politsky JM, Li PP, Kish SJ, Hornykiewicz O. Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease. Journal of Neurochemistry. 56: 1417-22. PMID 1825844 DOI: 10.1111/J.1471-4159.1991.Tb11440.X |
0.365 |
|
1991 |
Kish SJ, Du F, Parks DA, Robitaille Y, Ball MJ, Schut L, Hornykiewicz O, Schwarcz R. Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 29: 100-4. PMID 1825460 DOI: 10.1002/Ana.410290119 |
0.366 |
|
1991 |
Kish SJ, Wilson JM, Fletcher PJ. The polyamine synthesis inhibitor α-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo European Journal of Pharmacology. 209: 101-103. PMID 1814755 DOI: 10.1016/0014-2999(91)90017-K |
0.335 |
|
1991 |
Kish SJ, Robitaille Y, el-Awar M, Gilbert J, Deck J, Chang LJ, Schut L. Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 30: 780-4. PMID 1686387 DOI: 10.1002/Ana.410300606 |
0.385 |
|
1990 |
Kish SJ, Robitaille Y, Ball M, Gilbert J, Deck JH, Chang LJ, Schut L. Glycerophosphoethanolamine concentration is elevated in brain of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 120: 209-11. PMID 2293106 DOI: 10.1016/0304-3940(90)90040-G |
0.41 |
|
1990 |
Nobrega JN, Kish SJ, Burnham WM. Regional brain [3H]muscimol binding in kindled rat brain: a quantitative autoradiographic examination. Epilepsy Research. 6: 102-9. PMID 2167222 DOI: 10.1016/0920-1211(90)90084-9 |
0.346 |
|
1990 |
Kish SJ, Distefano LM, Dozic S, Robitaille Y, Rajput A, Deck JH, Hornykiewicz O. [3H]vesamicol binding in human brain cholinergic deficiency disorders. Neuroscience Letters. 117: 347-52. PMID 2151294 DOI: 10.1016/0304-3940(90)90689-7 |
0.402 |
|
1990 |
Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C, Maurer E, Rezvani Y, Myers R, Hornykiewicz O. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. The American Journal of Psychiatry. 147: 1358-63. PMID 2133042 |
0.329 |
|
1990 |
Robitaille Y, Ball M, Schut L, Kish S. THE NIGROSTRIATAL DOPAMINE SYSTEM IN PATIENTS WITH DOMINANTLY-INHERITED OLIVOPONTOCEREBELLAR ATROPHY Journal of Neuropathology and Experimental Neurology. 49: 280. DOI: 10.1097/00005072-199005000-00065 |
0.35 |
|
1990 |
Kish S, Dozic S, Deck J, Shannak K, Hornykiewicz O. BRAIN NORADRENERGIC CHANGES IN A PATIENT WITH WILSONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 49: 280. DOI: 10.1097/00005072-199005000-00064 |
0.382 |
|
1989 |
Kish SJ, Robitaille Y, el-Awar M, Deck JH, Simmons J, Schut L, Chang LJ, DiStefano L, Freedman M. Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 26: 362-7. PMID 2802535 DOI: 10.1002/Ana.410260309 |
0.392 |
|
1989 |
Nobrega JN, Kish SJ, Burnham WM. Autoradiographic analysis of benzodiazepine binding in entorhinal-kindled rat brains. Brain Research. 498: 315-22. PMID 2790486 DOI: 10.1016/0006-8993(89)91110-4 |
0.344 |
|
1989 |
Kish SJ, Li PP, Robitaille Y, Currier R, Gilbert J, Schut L, Warsh JJ. Cerebellar [3H]inositol 1,4,5-trisphosphate binding is markedly decreased in human olivopontocerebellar atrophy. Brain Research. 489: 373-6. PMID 2787192 DOI: 10.1016/0006-8993(89)90874-3 |
0.335 |
|
1989 |
Kish S, Karlinsky H, Becker L, Gilbert J, Rebbetoy M, Chang LJ, DiStefano L, Hornykiewicz O. Down's syndrome individuals begin life with normal levels of brain cholinergic markers. Journal of Neurochemistry. 52: 1183-7. PMID 2522539 DOI: 10.1111/J.1471-4159.1989.Tb01864.X |
0.422 |
|
1988 |
Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine. 318: 876-80. PMID 3352672 DOI: 10.1056/Nejm198804073181402 |
0.394 |
|
1988 |
Young LT, Li PP, Kish SJ, Chiu AS, Warsh JJ. [3H]Inositol 1,4,5-trisphosphate binding in human cerebral cortex Neuroscience Letters. 87: 283-287. PMID 3260018 DOI: 10.1016/0304-3940(88)90462-4 |
0.32 |
|
1988 |
Kish SJ, Schut L, Simmons J, Gilbert J, Chang LJ, Rebbetoy M. Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 544-8. PMID 3164041 |
0.338 |
|
1988 |
Kish SJ, Dixon LM, Burnham WM, Perry TL, Becker L, Cheng J, Chang LJ, Rebbetoy M. Brain neurotransmitters in glycine encephalopathy. Annals of Neurology. 24: 458-61. PMID 2906530 DOI: 10.1002/Ana.410240319 |
0.362 |
|
1988 |
Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz O. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Annals of Neurology. 24: 688-91. PMID 2904794 DOI: 10.1002/Ana.410240518 |
0.356 |
|
1988 |
Young LT, Kish SJ, Li PP, Warsh JJ. Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease Neuroscience Letters. 94: 198-202. PMID 2853852 DOI: 10.1016/0304-3940(88)90295-9 |
0.365 |
|
1988 |
KARLINSKY H, KISH S, BECKER L, GILBERT J, REBBETOY M, CHANG L, HORNYKIEWICZ O. BRAIN CHOLINEACETYLTRANSFERASE AND ACETYLCHOLINESTERASE ARE NOT REDUCED IN INFANT DOWN??S SYNDROME BRAIN Alzheimer Disease & Associated Disorders. 2: 242. DOI: 10.1097/00002093-198802030-00091 |
0.355 |
|
1987 |
Perry TL, Yong VW, Godolphin WJ, Sutter M, Hansen S, Kish SJ, Foulks JG, Ito M. Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration. Neurochemical Research. 12: 369-75. PMID 3600963 DOI: 10.1007/Bf00993247 |
0.367 |
|
1987 |
Kish SJ, Currier RD, Schut L, Perry TL, Morito CL. Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 22: 272-5. PMID 3477997 DOI: 10.1002/Ana.410220214 |
0.431 |
|
1987 |
Kish SJ, Shannak K, Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Annals of Neurology. 22: 386-9. PMID 2445259 DOI: 10.1002/Ana.410220318 |
0.382 |
|
1986 |
Kish SJ, Morito CL, Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochemical Pathology. 4: 23-8. PMID 2940481 DOI: 10.1007/Bf02834296 |
0.44 |
|
1986 |
Kish SJ, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss. Annals of Neurology. 20: 26-31. PMID 2874765 DOI: 10.1002/Ana.410200106 |
0.384 |
|
1986 |
Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Brain neurotransmitters in dystonia musculorum deformans. The New England Journal of Medicine. 315: 347-53. PMID 2426591 DOI: 10.1056/Nejm198608073150602 |
0.425 |
|
1985 |
Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, Kish SJ. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Annals of Neurology. 18: 482-9. PMID 4073841 DOI: 10.1002/Ana.410180411 |
0.383 |
|
1985 |
Kish SJ, Morito C, Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neuroscience Letters. 58: 343-6. PMID 4047494 DOI: 10.1016/0304-3940(85)90078-3 |
0.457 |
|
1985 |
Sweeney VP, Perry TL, Price JD, Reeve CE, Godolphin WJ, Kish SJ. Brain gamma-aminobutyric acid deficiency in dialysis encephalopathy. Neurology. 35: 180-4. PMID 3969205 DOI: 10.1212/Wnl.35.2.180 |
0.361 |
|
1985 |
Perry TL, Yong VW, Hansen S, Foulks JG, Kish SJ. Is a circulating neurotoxin involved in the pathogenesis of Huntington's chorea? Journal of the Neurological Sciences. 67: 351-8. PMID 3157785 DOI: 10.1016/0022-510X(85)90160-1 |
0.313 |
|
1985 |
Kish SJ, Perry TL, Sweeney VP, Hornykiewicz O. Brain gamma-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy. Neuroscience Letters. 58: 241-4. PMID 2995877 DOI: 10.1016/0304-3940(85)90171-5 |
0.325 |
|
1985 |
Kish SJ, Fox IH, Kapur BM, Lloyd K, Hornykiewicz O. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome. Brain Research. 336: 117-23. PMID 2988699 DOI: 10.1016/0006-8993(85)90422-6 |
0.365 |
|
1985 |
Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers. Annals of Neurology. 18: 530-6. PMID 2416269 DOI: 10.1002/Ana.410180504 |
0.47 |
|
1985 |
Perry TL, Yong VW, Kish SJ, Ito M, Foulks JG, Godolphin WJ, Sweeney VP. Neurochemical abnormalities in brains of renal failure patients treated by repeated hemodialysis. Journal of Neurochemistry. 45: 1043-8. PMID 2411864 DOI: 10.1111/J.1471-4159.1985.Tb05521.X |
0.427 |
|
1985 |
Kish SJ, Gilbert JJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Annals of Neurology. 17: 405-7. PMID 2408557 DOI: 10.1002/Ana.410170419 |
0.442 |
|
1984 |
Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of Neurology. 41: 612-4. PMID 6721735 DOI: 10.1001/Archneur.1984.04210080020007 |
0.402 |
|
1984 |
Kish SJ, Shannak KS, Hornykiewicz O. Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy. Journal of Neurochemistry. 42: 1476-8. PMID 6707646 DOI: 10.1111/J.1471-4159.1984.Tb02813.X |
0.33 |
|
1984 |
Perry TL, Kish SJ, Hinton D, Hansen S, Becker LE, Gelfand EW. Neurochemical abnormalities in a patient with ataxia-telangiectasia. Neurology. 34: 187-91. PMID 6320055 DOI: 10.1212/Wnl.34.2.187 |
0.366 |
|
1984 |
Kish SJ, Perry TL, Hornykiewicz O. Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy. Journal of Neurochemistry. 42: 466-9. PMID 6319600 DOI: 10.1111/J.1471-4159.1984.Tb02700.X |
0.306 |
|
1984 |
Hornykiewicz O, Kish SJ. Neurochemical basis of dementia in Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 185-90. PMID 6143610 DOI: 10.1017/S0317167100046382 |
0.388 |
|
1984 |
Niznik HB, Burnham WM, Kish SJ. Benzodiazepine receptor binding following amygdala-kindled convulsions: differing results in washed and unwashed brain membranes. Journal of Neurochemistry. 43: 1732-6. PMID 6092546 DOI: 10.1111/J.1471-4159.1984.Tb06101.X |
0.346 |
|
1983 |
Burnham WM, Niznik HB, Okazaki MM, Kish SJ. Binding of [3H]flunitrazepam and [3H]Ro5-4864 to crude homogenates of amygdala-kindled rat brain: two months post-seizure. Brain Research. 279: 359-62. PMID 6315180 DOI: 10.1016/0006-8993(83)90210-X |
0.309 |
|
1983 |
Niznik HB, Kish SJ, Burnham WM. Decreased benzodiazepine receptor binding in amygdala-kindled rat brains. Life Sciences. 33: 425-30. PMID 6308374 DOI: 10.1016/0024-3205(83)90790-7 |
0.347 |
|
1983 |
Kish SJ, Shannak KS, Perry TL, Hornykiewicz O. Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum. Journal of Neurochemistry. 41: 1495-7. PMID 6137518 DOI: 10.1111/J.1471-4159.1983.Tb00852.X |
0.308 |
|
1981 |
Perry TL, Kish SJ, Hansen S, Currier RD. Neurotransmitter amino acids in dominantly inherited cerebellar disorders Neurology. 31: 237-242. PMID 6111044 DOI: 10.1212/Wnl.31.3.237 |
0.349 |
|
1979 |
Perry TL, Kish SJ, Sjaastad O, Gjessing LR, Nesbakken R, Schrader H, Løken AC. Homocarnosinosis: increased content of homocarnosine and deficiency of homocarnosinase in brain. Journal of Neurochemistry. 32: 1637-40. PMID 448356 DOI: 10.1111/J.1471-4159.1979.Tb02273.X |
0.428 |
|
Show low-probability matches. |